SCHEMBL4182156

SCHEMBL4182156

COc1cc(C(=O)Nc2cncc(Br)c2)ccc1C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.54
ALDH1A1 P00352 4/20 0.52
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
PKM P14618 1/20 0.52
GAA P10253 2/20 0.49
KDM4E B2RXH2 1/20 0.49
MAPT P10636 1/20 0.49
MAPK1 P28482 1/20 0.49
PDE4D Q08499 1/20 0.49
ABCB1 P08183 1/20 0.49
IMPDH2 P12268 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
SMN1; SMN2 Q16637 5/20 0.48
HTT P42858 3/20 0.48
ROCK2 O75116 1/20 0.48
ALOX12 P18054 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15649419 0.82 RAB9A (0.63) ALDH1A1MEN1KMT2APKMGAA
SCHEMBL13947089 0.81 LMNA (0.81) LMNAALDH1A1MEN1KMT2AGAA
SCHEMBL13947128 0.80 KMT2A (0.79) LMNAALDH1A1MEN1KMT2APKM
SCHEMBL15648936 0.79 ALDH1A1 (0.69) ALDH1A1MEN1KMT2APKMKDM4E
SCHEMBL4201138 0.78 LMNA (0.50) LMNAALDH1A1MEN1KMT2APKM
SCHEMBL13947237 0.77 KMT2A (0.70) LMNAALDH1A1MEN1KMT2APKM
SCHEMBL13947385 0.76 RAB9A (0.69) ALDH1A1MEN1KMT2AGAAKDM4E
SCHEMBL12436011 0.76 ATM (0.64) LMNAALDH1A1MEN1KMT2AGAA
SCHEMBL10428614 0.75 HDAC8 (0.62) ALDH1A1MEN1KMT2APKMKDM4E
SCHEMBL14880129 0.75 HDAC1 (0.59) PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090196912-A1 Pyridinylamines GPC BOTECH AG (DE) 2009-08-06 US disclosed
US-20090196912-A1 Pyridinylamines GPC BOTECH AG (DE) 2009-08-06 US disclosed
US-20090196912-A1 Pyridinylamines GPC BOTECH AG (DE) 2009-08-06 US disclosed
EP-1789393-A2 PYRIDINYLAMINES GPC Biotech AG (DE) 2007-05-30 EP disclosed
WO-2006010637-A2 PYRIDINYLAMINES GPC BIOTECH AG (DE) 2006-02-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090196912-A1 Pyridinylamines PRNP, PLPBP, SNCA LMNA 627/4885ALDH1A1 1221/4885MEN1 826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.